business development

ImmunoCellular believes that the company’s proprietary cancer immunotherapy technology platform is broadly enabling, with the potential to generate many immunotherapeutic products that can improve cancer treatment and bring meaningful benefit to patients and their families

ImmunoCellular welcomes inquiries from pharmaceutical and biotechnology companies, academic institutions, and other potential collaborators. For more information, please contact busdev@imuc.com

Copyright 2017 by Immunocellular Therapeutics, Ltd.
All Rights Reserved